12/8
09:00 am
sint
SINTX Technologies to Participate in Sidoti & Company Investor Conference
Low
Report
SINTX Technologies to Participate in Sidoti & Company Investor Conference
12/8
08:07 am
sint
Sintx Technologies (NASDAQ:SINT) had its price target lowered by analysts at Ascendiant Capital Markets from $25.00 to $16.00. They now have a "buy" rating on the stock.
Low
Report
Sintx Technologies (NASDAQ:SINT) had its price target lowered by analysts at Ascendiant Capital Markets from $25.00 to $16.00. They now have a "buy" rating on the stock.
12/1
09:44 am
sint
SINTX Technologies Signs Supply Agreement with EVONIK to Manufacture Silicon Nitride–PEEK Compound for AI-Assisted, 3D-Printed Patient-Specific Implants [Yahoo! Finance]
High
Report
SINTX Technologies Signs Supply Agreement with EVONIK to Manufacture Silicon Nitride–PEEK Compound for AI-Assisted, 3D-Printed Patient-Specific Implants [Yahoo! Finance]
12/1
08:30 am
sint
SINTX Technologies Signs Supply Agreement with EVONIK to Manufacture Silicon Nitride–PEEK Compound for AI-Assisted, 3D-Printed Patient-Specific Implants
High
Report
SINTX Technologies Signs Supply Agreement with EVONIK to Manufacture Silicon Nitride–PEEK Compound for AI-Assisted, 3D-Printed Patient-Specific Implants
11/15
12:43 am
sint
Sintx Technologies GAAP EPS of -$3.46 misses by $2.95, revenue of $0.21M misses by $0.09M [Seeking Alpha]
High
Report
Sintx Technologies GAAP EPS of -$3.46 misses by $2.95, revenue of $0.21M misses by $0.09M [Seeking Alpha]
11/13
08:38 am
sint
SINTX Reports Pivotal Third Quarter Business Update and Financial Highlights Driven by FDA Clearance, Product and IP Portfolio Expansions and Increased Operational Efficiencies [Yahoo! Finance]
High
Report
SINTX Reports Pivotal Third Quarter Business Update and Financial Highlights Driven by FDA Clearance, Product and IP Portfolio Expansions and Increased Operational Efficiencies [Yahoo! Finance]
11/13
08:00 am
sint
SINTX Reports Pivotal Third Quarter Business Update and Financial Highlights Driven by FDA Clearance, Product and IP Portfolio Expansions and Increased Operational Efficiencies
Medium
Report
SINTX Reports Pivotal Third Quarter Business Update and Financial Highlights Driven by FDA Clearance, Product and IP Portfolio Expansions and Increased Operational Efficiencies
11/3
08:00 am
sint
SINTX Technologies Announces Launch of OsseoSculpt™ an Advanced Biologic for Use with SINAPTIC® Foot & Ankle Osteotomy Wedge System
Medium
Report
SINTX Technologies Announces Launch of OsseoSculpt™ an Advanced Biologic for Use with SINAPTIC® Foot & Ankle Osteotomy Wedge System